On Monday, Cellectar Biosciences Inc (NASDAQ: CLRB) opened higher 4.57% from the last session, before settling in for the closing price of $0.30. Price fluctuations for CLRB have ranged from $0.22 to $4.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 48.15% at the time writing. With a float of $44.71 million, this company’s outstanding shares have now reached $46.08 million.
The extent of productivity of a business whose workforce counts for 23 workers is very important to gauge. In terms of profitability, gross margin is 32.05%, operating margin of -15613.22%, and the pretax margin is -13522.69%.
Cellectar Biosciences Inc (CLRB) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cellectar Biosciences Inc is 2.97%, while institutional ownership is 19.92%.
Cellectar Biosciences Inc (CLRB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.07% during the next five years compared to 41.77% growth over the previous five years of trading.
Cellectar Biosciences Inc (NASDAQ: CLRB) Trading Performance Indicators
Check out the current performance indicators for Cellectar Biosciences Inc (CLRB). In the past quarter, the stock posted a quick ratio of 1.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.87, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of Cellectar Biosciences Inc (CLRB)
The latest stats from [Cellectar Biosciences Inc, CLRB] show that its last 5-days average volume of 2.26 million was inferior to 2.33 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 81.86%. Additionally, its Average True Range was 0.03.
During the past 100 days, Cellectar Biosciences Inc’s (CLRB) raw stochastic average was set at 4.42%, which indicates a significant decrease from 83.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.98% in the past 14 days, which was lower than the 237.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5091, while its 200-day Moving Average is $1.9409. Now, the first resistance to watch is $0.3288. This is followed by the second major resistance level at $0.3439. The third major resistance level sits at $0.3579. If the price goes on to break the first support level at $0.2997, it is likely to go to the next support level at $0.2857. The third support level lies at $0.2706 if the price breaches the second support level.
Cellectar Biosciences Inc (NASDAQ: CLRB) Key Stats
There are currently 46,080K shares outstanding in the company with a market cap of 14.45 million. Presently, the company’s annual sales total 0 K according to its annual income of -37,980 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -14,660 K.
